top of page
Rinnit logo – modern health products and health news

Atypical Hyperplasia of the Breast: Symptoms, Causes, Risk & Treatment — Complete Guide

Oct 12
13 min read

Updated: 2 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer

Atypical hyperplasia of the breast is a buildup of precancerous cells in breast tissue. It is not cancer but raises breast cancer risk roughly four times above average. It usually causes no symptoms and is managed with personalized screening, plus risk-lowering medicines or surgery for some. Still, 70 out of 100 women diagnosed will not develop cancer within 25 years.

What the research says

  • Atypia raises risk about fourfold, and the extra risk lasts for decades. In a Mayo Clinic cohort of 9,087 women with benign breast disease followed for a median of 15 years, atypical hyperplasia (found in 4%) carried a relative risk of breast cancer of 4.24 (95% CI 3.26–5.41), versus 1.88 for proliferative changes without atypia and 1.27 for nonproliferative lesions; the cohort's overall increased risk persisted for at least 25 years after biopsy, and family history of breast cancer was an independent risk factor. (Hartmann et al., N Engl J Med, 2005) [3]

  • Women with atypical hyperplasia are among those most likely to benefit from risk-lowering medicines, yet few use them. A review of breast cancer chemoprevention describes tamoxifen, raloxifene, anastrozole and exemestane as preventive options and identifies women with atypical hyperplasia, and high-risk women under 50, as most likely to benefit, while noting that uptake has been low because of physician and patient barriers. (Pruthi et al., Ann Surg Oncol, 2015) [4]

At a Glance

Aspect

Summary

What it is

Precancerous cell buildup in breast tissue; not breast cancer

Symptoms

Usually none; typically found during a breast biopsy

Who is affected

Women; risk factor unknown — no specific cause identified

Types

Atypical ductal hyperplasia (ADH, most common) and atypical lobular hyperplasia (ALH)

Cancer risk

About 4x higher than average; similar for both types

25-year outlook

About 30 of 100 diagnosed women develop breast cancer; 70 do not

Diagnosis

Breast biopsy (usually after a mammogram or ultrasound concern)

Management

Personalized screening plan, lifestyle steps, optional risk-lowering medicines or surgery

Key message

Increased risk is manageable — early detection through screening works

The five-stage progression of breast cell changes: A normal duct, B hyperplasia (overgrowth of normal-looking cells), C atypical hyperplasia (cells that look irregular), D ductal carcinoma in situ (irregular cells trapped inside the duct wall), and E invasive breast cancer (cells breaking out of the duct), with key facts: precancerous and not breast cancer, about 4x higher breast cancer risk, and 30 of 100 develop breast cancer within 25 years. Image: rinnit.com – rinnit.com
Diagram: The five-stage progression of breast cell changes — from a normal duct to atypical hyperplasia to invasive breast cancer. Image courtesy of rinnit.com.

What Is Atypical Hyperplasia?

Atypical hyperplasia is the development of precancerous cells in the breast. It causes a buildup of cells in the breast tissue, and when those cells are viewed under a microscope, they look different from typical breast cells.

To understand where this happens, it helps to picture breast anatomy. Each breast contains 15 to 20 lobes of glandular tissue, arranged like the petals of a daisy. The lobes are divided into smaller lobules that produce milk for breastfeeding. Small tubes called ducts carry the milk to a reservoir that lies just beneath the nipple.

It is important to say this clearly: atypical hyperplasia is not breast cancer. It is a sign that your risk of breast cancer in the future is increased. Your healthcare team will create a plan to manage that risk — usually more-frequent breast cancer screening tests, and in some cases medicines to reduce risk.

Why is atypical hyperplasia of the breast usually found by accident?

Atypical hyperplasia usually causes no symptoms at all. This is one of the most important things to understand about the condition — there is nothing to feel or notice.

Atypical hyperplasia is typically discovered during a breast biopsy, a procedure that removes some breast cells for testing. A biopsy is often recommended if something concerning is found on a mammogram or an ultrasound. A biopsy might also be done to investigate a breast concern, such as a lump.

When to See a Doctor

Since atypical hyperplasia itself has no symptoms, the practical guidance is simple: make an appointment with a healthcare professional if you have any symptoms that worry you. A new change, a lump, or something not typical in your breasts should be reported promptly.

What are the two types of atypical hyperplasia of the breast?

Atypical hyperplasia can develop in the breast ducts or the breast lobules. Both types increase the risk of breast cancer, and treatment for both types is similar.

Type

Where it develops

How common

Atypical ductal hyperplasia (ADH)

Within the breast ducts — the tubes that carry breast milk to the nipple

Most common

Atypical lobular hyperplasia (ALH)

Within the breast lobules — the glands that make breast milk

Less common

Infographic on atypical hyperplasia: key facts (precancerous cell changes, not cancer; about 4x higher breast cancer risk; often no symptoms), the two types (atypical ductal hyperplasia in the ducts, most common; atypical lobular hyperplasia in the lobules, less common), usually found during a biopsy, ways to lower breast cancer risk, and how a care team manages risk with more-frequent screening, breast MRI, risk-lowering medicines, or surgery in select cases. Image: rinnit.com – rinnit.com
Infographic: The two types of atypical hyperplasia, key risk facts, and practical steps to lower your breast cancer risk. Image courtesy of rinnit.com.

What Causes Atypical Hyperplasia?

The exact cause is not clear. What is known is the mechanism: atypical hyperplasia happens when cells in the breast tissue develop changes in their DNA. A cell's DNA holds the instructions that tell the cell what to do. When those instructions change, two things happen. The cell makes many more cells than it should — healthcare professionals call this buildup hyperplasia. And the cells themselves change so they look different from typical cells — that makes them atypical.

Atypical hyperplasia is thought to be a very early step in the process that turns healthy cells into cancer cells. In theory, if atypical hyperplasia cells were allowed to keep growing, they could accumulate more DNA changes and become cancer cells. More research is needed to understand exactly how this happens.

The diagram above shows how breast cancer can develop over time: a typical breast duct (A), an overgrowth of cells in the duct called hyperplasia (B), cells that change and look different called atypical hyperplasia (C), atypical cells trapped inside the duct called ductal carcinoma in situ (DCIS) (D), and finally cancer cells that break out of the duct and become invasive breast cancer (E).

What are the risk factors for atypical hyperplasia of the breast?

Atypical hyperplasia of the breast has no specific risk factors of its own, but researchers have identified risk factors for benign breast diseases in general. It is one of several conditions that cause a noncancerous growth of cells in the breast — conditions sometimes called benign breast diseases. Researchers have identified risk factors for benign breast diseases in general.

Risk factor

How it works

Family history of breast cancer

If a parent, sibling, or child had breast cancer, your risk of being diagnosed with atypical hyperplasia or another benign breast disease before menopause is increased

Menopausal hormone therapy

Taking certain hormone therapy medicines to control menopause symptoms may increase the risk of atypical hyperplasia and other benign breast diseases

What do the complication numbers for atypical hyperplasia really mean?

The main complication of an atypical hyperplasia diagnosis is an increased risk of breast cancer in the future. Understanding what that actually means — and what it does not mean — is essential.

The risk of breast cancer in people with atypical hyperplasia is about four times higher than in people without it. The risk is similar whether the diagnosis is atypical ductal hyperplasia or atypical lobular hyperplasia.

And the risk grows over time. Studies following women with atypical hyperplasia found that at 25 years after diagnosis, about 30% of women may develop breast cancer. Put another way, for every 100 women diagnosed with atypical hyperplasia, 30 can be expected to have breast cancer 25 years after diagnosis — and 70 will not.

That framing matters. The majority of women diagnosed with this condition never develop breast cancer, and a screening plan exists precisely to catch problems early, when they are most treatable.

Can atypical hyperplasia of the breast be prevented?

Whether anything can directly prevent atypical hyperplasia of the breast is not clear, though habits that lower breast cancer risk may also help. But the same habits that lower the risk of breast cancer may also lower the risk of atypical hyperplasia.

Habit

What to do

Breast cancer screening

Talk with your doctor about when to begin screening and which tests are right for you, weighing benefits and risks together

Breast self-exam for awareness

Occasionally inspect your breasts so you know their typical look and feel; report any new change or lump right away. Awareness can't prevent breast cancer, but it helps you notice changes

Alcohol in moderation

Limit to no more than one drink a day if you drink. For breast cancer prevention there is no safe amount of alcohol — if you are very concerned about risk, you may choose not to drink

Exercise

At least 30 minutes of exercise on most days of the week; if you haven't been active lately, ask a professional whether it's OK and start slowly

Healthy weight

Maintain a healthy weight; if you need to lose weight, eat fewer calories and slowly increase exercise

Hormone therapy

Use the lowest dose of menopausal hormone therapy for the shortest time possible, after discussing benefits and risks

How is atypical hyperplasia of the breast diagnosed?

Atypical hyperplasia is most often diagnosed during a breast biopsy — a procedure that removes a sample of breast tissue for testing in the lab. A biopsy is usually done if something concerning is found during a clinical breast exam or on an imaging test such as a mammogram or an ultrasound.

In other words, atypical hyperplasia is a pathology finding, not something seen on a scan. The mammogram or ultrasound raises the concern; only the biopsy can reveal that the cells are atypical.

How is atypical hyperplasia of the breast treated and its risk managed?

Treatment for atypical hyperplasia may involve surgery to remove the atypical cells — but not everyone needs surgery. Your healthcare team might instead recommend more-frequent breast cancer screening to watch for signs of breast cancer, and you might consider medicine to lower your risk.

Surgery: When It Is Recommended

Surgery may be recommended to remove the atypical cells, particularly if mammogram images show something concerning. Your care team typically decides based on your imaging test results, your biopsy results, and other factors such as your medical history and past breast operations.

If you have surgery, the tissue removed is tested in the lab for signs of cancer. Most people who have surgery for atypical hyperplasia do not have breast cancer. But sometimes the surgery finds noninvasive breast cancer (ductal carcinoma in situ) or invasive breast cancer — which is exactly why the tissue gets tested.

Some care teams may not recommend surgery if the risk of finding cancer is low. The level of risk depends on your mammogram findings, your medical history, and your previous breast operations. Your team carefully weighs all of these when choosing the plan that fits you.

Medicines That Lower Breast Cancer Risk

Medicines that block the hormone estrogen can lower breast cancer risk. Most breast cancers use estrogen and other hormones to help the cancer grow, so blocking estrogen helps stop cancer from forming.

Medicine

Notes

Tamoxifen

Sometimes taken in a lower dose every other day

Raloxifene (Evista)

Hormone-blocking medicine taken to reduce risk

Anastrozole (Arimidex)

Hormone-blocking medicine taken to reduce risk

Exemestane (Aromasin)

Hormone-blocking medicine taken to reduce risk

These medicines are typically taken daily for five years to reduce breast cancer risk. Tamoxifen and raloxifene carry boxed warnings for blood clots and stroke, and tamoxifen also for uterine cancer, while anastrozole and exemestane can cause bone thinning and joint pain. Talk with your healthcare team about which medicine is best for you.

A Personalized Screening Plan

Because atypical hyperplasia increases breast cancer risk, your care team creates a screening plan that may include more-frequent screening or different tests than someone with average risk.

Screening step

Typical schedule

Breast self-exams for awareness

Occasionally, to learn the typical look and feel of your breasts

Clinical breast exams

Once or twice a year

Screening mammograms

Once a year

Additional tests

Breast MRI, molecular breast imaging, or other supplemental imaging, depending on your risk factors, family history, DNA changes, and whether you have dense breasts

Which additional test is best for you depends on your individual risk factors — your family history, whether you carry DNA changes that increase breast cancer risk, and whether your mammogram images show dense breasts.

Other Ways to Lower Your Risk

Beyond screening and medicines, your care team may recommend additional options depending on your situation.

Avoiding hormone therapy for menopause is one step: certain hormone medicines can increase breast cancer risk, so if you have menopause symptoms, ask about treatments that won't increase your risk.

If your risk is very high — for example, a strong family history of breast cancer or DNA changes that run in your family — your team might discuss surgery to lower risk, such as a risk-reducing (prophylactic) mastectomy to remove both breasts.

Healthy lifestyle choices also matter: exercise most days, maintain a healthy weight, don't smoke, and limit alcohol. And you can ask about clinical trials testing the best way to manage breast cancer risk in people with atypical hyperplasia.

How can you cope with atypical hyperplasia of the breast?

Finding out you have atypical hyperplasia can feel stressful. Many people worry about their breast cancer risk after the diagnosis. With time, you will find your own way of coping. Three approaches are especially helpful.

Understand your individual risk. Breast cancer risk statistics can be overwhelming and worrisome. Those statistics are calculated by following many people with atypical hyperplasia and monitoring them — they give you an idea of the outlook, but they cannot tell you your own risk. Ask your healthcare professional to explain your individual risk, so you can make comfortable decisions about your care.

Go to all of your follow-up appointments. With this diagnosis, you may need more-frequent screening exams and tests, and it is common to feel anxious before them. Don't let that worry keep you away. Find activities that help you cope — relax, write your feelings in a journal, or spend time with a close friend who can lift your spirits.

Talk with others in your situation. Connect with other people who have been diagnosed with atypical hyperplasia. Ask your healthcare team about support groups in your community and online.

How should you prepare for an atypical hyperplasia appointment?

If a mammogram reveals a suspicious area, you may be referred to a breast health specialist or a specialized breast center. A breast health specialist can help you understand your breast cancer risk and create a plan to manage it.

Before your appointment, try to do the following:

  1. Check for pre-appointment restrictions — ask when you book whether you need to do anything in advance, such as restricting your diet.

  2. Write down any symptoms you're experiencing, including ones that seem unrelated.

  3. Write down key personal information — major stresses or recent life changes.

  4. List all medications, vitamins, and supplements you're taking.

  5. Consider bringing a family member or friend — it can be hard to absorb everything during an appointment, and someone with you may remember things you miss.

Questions to Ask Your Doctor

  • Can you explain my pathology report to me?

  • Do I need more tests?

  • Will I need surgery for atypical hyperplasia?

  • Are there medicines I can take to lower my risk of breast cancer?

  • What can I do to reduce my risk of breast cancer?

  • What symptoms of breast cancer should I watch for?

  • How often should I have a mammogram to screen for breast cancer?

  • Should I also have an MRI to screen for breast cancer?

  • What would you recommend to a friend or family member in my situation?

  • Are there any restrictions I need to follow?

  • Should I see a breast health specialist? What will that cost, and will my insurance cover it?

  • Should I consider genetic counseling?

  • Are there brochures or other printed material I can take? What websites do you recommend?

What Your Doctor May Ask

  • Do you have a family history of breast cancer?

  • Do you have a family history of other types of cancer?

  • Have you had a breast biopsy before, and do you know the results of previous biopsies?

Frequently Asked Questions

What is atypical hyperplasia of the breast?

Atypical hyperplasia of the breast is a buildup of precancerous cells in breast tissue. Under a microscope, these cells look different from typical breast cells. It is not breast cancer, but it means your future risk of breast cancer is higher than average.

Is atypical hyperplasia breast cancer?

No. Atypical hyperplasia is not breast cancer. It is a precancerous cell change that signals an increased risk of breast cancer developing in the future. Think of it as an early warning sign that justifies a careful screening plan — not a cancer diagnosis.

Does atypical hyperplasia cause symptoms?

Usually not. Atypical hyperplasia typically causes no symptoms and is most often found during a breast biopsy performed after a concerning mammogram, ultrasound, or clinical exam finding. That's why reporting any new breast change to a doctor promptly matters.

What is the difference between ADH and ALH?

Atypical ductal hyperplasia (ADH) means atypical cells are growing in the breast ducts, the tubes that carry milk to the nipple, and it is the most common type. Atypical lobular hyperplasia (ALH) means atypical cells are growing in the breast lobules, the glands that make milk, and it is less common. Both increase breast cancer risk similarly, and treatment for both is similar.

How much does atypical hyperplasia increase breast cancer risk?

The breast cancer risk is about four times higher than in people without atypical hyperplasia. However, the long-term picture is reassuring for most women: 25 years after diagnosis, about 30 out of 100 women with atypical hyperplasia develop breast cancer — and 70 do not.

Does atypical hyperplasia require surgery?

Not always. Many people never need surgery and are managed with more-frequent screening instead. Surgery may be recommended if mammogram images show something concerning, and tissue removed during surgery is always tested for cancer. Some teams may not recommend surgery when the risk of finding cancer is low.

What medicines can lower my breast cancer risk?

Hormone-blocking medicines such as tamoxifen, raloxifene (Evista), anastrozole (Arimidex), and exemestane (Aromasin) can lower breast cancer risk by blocking estrogen, which most breast cancers use to grow. These are typically taken daily for five years, and tamoxifen is sometimes taken at a lower dose every other day.

What breast screening is recommended after atypical hyperplasia?

Most people need more frequent screening than average, often with yearly mammograms and sometimes breast MRI. Your healthcare team will set a plan based on your overall risk.

Can lifestyle changes lower breast cancer risk after atypical hyperplasia?

Yes, healthy habits may help. Limiting alcohol, staying physically active, and keeping a healthy weight are commonly advised ways to lower breast cancer risk.

Should I have genetic testing if I have atypical hyperplasia?

Atypical hyperplasia itself is not usually inherited. Genetic counseling may be offered if you have a strong family history of breast or ovarian cancer.

Conclusion

Atypical hyperplasia of the breast is a diagnosis about risk management, not about cancer today. The condition itself causes no symptoms, is discovered through biopsy, and raises breast cancer risk about fourfold — but the majority of women diagnosed will never develop breast cancer within 25 years.

This guide has walked you through what atypical hyperplasia is, the two types (ADH and ALH), what the risk numbers actually mean, and the full range of management options: a personalized screening plan, lifestyle steps that lower risk, optional risk-lowering medicines, and surgery in selected cases. The single most important takeaway is that this diagnosis puts you on a watchful, proactive path — with regular mammograms, clinical exams, and a care team that knows your individual risk.

Disclaimer: This article is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment.

Related Reading

Breast Cancer Risk Assessment: Tools, Risk Factors and What Your Score Means explains the tools doctors use to estimate breast cancer risk.

References

  1. Mayo Clinic. Atypical hyperplasia of the breast — Symptoms & causes. Accessed October 12, 2026. https://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/symptoms-causes/syc-20369773

  2. Mayo Clinic. Atypical hyperplasia of the breast — Diagnosis & treatment. Accessed October 12, 2026. https://www.mayoclinic.org/diseases-conditions/atypical-hyperplasia/diagnosis-treatment/drc-20369778

  3. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229-237. PMID 16034008. https://doi.org/10.1056/NEJMoa044383

  4. Pruthi S, Heisey RE, Bevers TB. Chemoprevention for breast cancer. Ann Surg Oncol. 2015;22(10):3230-3235. PMID 26202562. https://doi.org/10.1245/s10434-015-4715-9

Comments


bottom of page